Hanbury FZE
  • Search
  • Home
  • Products & Services
    • Nutraceutical Ingredients
      • Standardized Phyto Extracts
      • Beverage/Liquid Dietary Supplements
      • GRAS Affirmed Ingredients
      • Minerals for Nutritional Use
      • Phytochemicals for Nutritional Use
      • Multi-enzyme Blends
      • Natural Protein
      • Nutritional Fine Chemicals
      • Phyto Functional Blends
      • Geroceuticals™
      • Prebiotics, Probiotics, Postbiotics and Synbiotics
      • Super Critical Fluid (SCF) Extracts
      • Specialty Fine Chemicals
    • Cosmeceutical Ingredients
      • Natural Actives
      • Peptides
      • Anti-Glycation
      • Dermaceuticals
      • Nutricosmetics
      • Probiotics & Postbiotics
      • Proprietary Cosmeceutical Blends
      • Speciality Chemicals
    • Services
      • Custom Manufacturing
      • Contract Manufacturing
      • Product Specification Sheet
    • Pharma
      • Natural Drugs
      • Chiral Drug Intermediates
  • About Us
    • Our Story
    • Our People
    • Research & Development
    • Manufacturing Facilities
    • Intellectual Properties
  • Newsroom
    • Press Release
    • FAQs
      • BioPerine®
      • Citrin®K
      • Cococin™
      • Curcumin C3 Complex®
      • Curcumin C3 Reduct®
      • ForsLean®
      • GarCitrin®
      • LactoSpore®
      • LeanGard®
  • Contact Us

Home / Sami-Sabinsa Honored By Pharmexcil For Export Excellence

Sami-Sabinsa Honored By Pharmexcil For Export Excellence

Sami-Sabinsa Honored By Pharmexcil For Export Excellence

Sabinsa Corporation’s parent company Sami Labs, was recognized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) with a Silver Award for Outstanding Export Performance Award, Herbals & Pharma Allied Products for 2017 – 2018.

Pharmexcil, a ministry set up by the Government of India as a gateway to the global pharma trade, presents awards each year to acknowledge those companies that achieve significant export success. The awards were presented at Pharmexcil‘s 14th annual meeting, sponsored by Department of Commerce & Industry, Government of India. Dr. S. Natajaran, Sr. Vice President – R&D, Sami Labs, accepted the award on behalf of the company.

With offices around the world selling our well-researched products, we’re pleased to see such wide demand for the ingredients we make in India,” said Sami-Sabinsa Group founder Dr. Muhammed Majeed. “We thank Pharmexcil for their support in once again recognizing our success.”

Previous honors Sami Labs has received from Pharmexcil in the Herbals category include Outstanding Export Performance for 2016 – 2017, both Patents and Outstanding Export recognition for 2015 – 2016, the top Pharmexcil Patent Award for 2014 – 2015, in the 2012 – 2013 Herbals, Ayurveda & Nutraceuticals category: the Gold for Patents and the Silver for Exports in Herbals, and Patents for 2010 – 2011 in the Herbals, Ayurveda & Nutraceuticals category.

From Left – Mr. R. Uday Bhaskar-Director General, Pharmexcil, Dr. S Natarajan, Advisor / Sr. Vice President – R & D, Sami Labs, Mr. Madan Mohan Reddy-Former Chairman, Pharmexcil, Dr. Dinesh Dua-Chairman, Pharmexcil and Shri Navdeep Rinwa, Joint Secretary, Department of Pharmaceuticals, Government of India. 

Back
top

HEADQUARTERS

Hanbury FZE


Jebel Ali Free Zone


Warehouse No. RA08AB05


P O Box. 61091


Dubai


United Arab Emirates


+971 4 883 8981

+971 4 883 8978

mail@hanburyfze.ae

CERTIFICATES

Certificate Logos Certificate Logos Certificate LogosCertificate Logos

Global Contacts List

USA India
Utah, USA Japan
Australia Poland
Brasil Korea
Canada South Africa
China Vietnam
Germany  

CONTACT US

    © 2023 Hanbury FZE. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Terms of Use | Sitemap | Disclaimer

    • Facebook
    • Twitter
    • LinkedIn
    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.